ARHGAP42 pseudogene 4 (ARHGAP42P4)

ARHGAP42 pseudogene 4 (ARHGAP42P4) is designated as a pseudogene corresponding to the ARHGAP42 locus. Pseudogenes are generally non-functional sequences of genomic DNA originally derived from functional genes, often due to mutations or genomic rearrangements. As such, ARHGAP42P4 is not expected to encode a functional protein, nor is it considered a therapeutic target. There is no evidence that ARHGAP42P4 is implicated in disease, used as a biomarker, or is targeted by any drugs. Most research and clinical associations involve the functional gene ARHGAP42, not its pseudogenes[1][2][3]. Key considerations: - If you intended ARHGAP42 (Rho GTPase Activating Protein 42), this is a functional protein-coding gene involved in vascular smooth muscle tone, hypertension, and certain cancers[1][2][3]. - ARHGAP42P4 is not listed in major gene databases as a therapeutic or drug target, and there is no information supporting its functional relevance. - If more detailed information about the actual ARHGAP42 gene is needed, this can be provided, but for ARHGAP42P4, relevant structured information is minimal as it is not a targetable molecule. In summary: "ARHGAP42 pseudogene 4" is a non-functional pseudogene, not a drug target, with no disease, biological, or pharmacological roles described in the reviewed scientific literature[1][2][3]. If ARHGAP42P4 was listed as a therapeutic target, this is likely an error or a misinterpretation.